As of May 03
| 0.00 / 0.00%|
The 7 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 9.50, with a high estimate of 13.00 and a low estimate of 5.20. The median estimate represents a +112.53% increase from the last price of 4.47.
The current consensus among 7 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.